StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers
New York, NY -- (SBWIRE) -- 10/09/2013 -- StockRunway.com issues special report on – CEL-SCI Corporation(NYSEMKT:CVM), Newmont Mining Corp(NYSE:NEM), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Carnival Corporation(NYSE:CCL).
CEL-SCI Corporation(NYSEMKT:CVM) stock is at $0.839, down -32.34 percent. The stock opened the session at $0.89 and touched its highest price point at $0.92.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative with -58.05% during previous three months trade. Its recent trading volume was 8.29 million shares in comparison to its usual trading volume of 191,293. shares.
CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company?s principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer.
Has CVM Found The Bottom and Ready To Move Up? Find Out Here
Newmont Mining Corp(NYSE:NEM) stock is at $26.35, down -3.02 percent. Its today’s volume is 100.00 shares in comparison to its usual trading volume of 9.01 million shares. The stock opened the session at $27.21 and touched its highest price point at $27.47.
NEM quarterly performance remained red with the percentage of -2.48, while its year to date performance showed that the stock plunged overall -41.48%.
Newmont Mining Corporation, together with its subsidiaries, engages in the acquisition, exploration, and production of gold and copper properties. The company?s assets or operations are located in the United States, Australia, Peru, Indonesia, Ghana, Mexico, and New Zealand.
Has NEM Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) experienced a plungeof -5.71% to a market valuation of $218.25 per share for previous trading session. After opening the day at $4.72 per share, volume surged to 7.46 million.
During last one month it slipped with the percentage of XX. Its year to date performance remained adverse with -30.2%.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Carnival Corporation(NYSE:CCL) opened its shares at the price of $32.17 for the day, its closing price was $31.72 after losing -1.46% for the day. The company traded with the total volume of 3,0.98 shares while its average trading aptitude remained 5.26 million shares. The company has total of 775.92 million outstanding shares and its total market capitalization is $24.61 billion.
Carnival Corporation operates as a cruise and vacation company worldwide. The company operates in two segments, North America; and Europe, Australia, and Asia.
Will CCL Get Buyers Even After The Recent Rally? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)